Ignite Creation Date:
2024-05-06 @ 3:05 PM
Last Modification Date:
2024-10-26 @ 1:42 PM
Study NCT ID:
NCT04517851
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-06-27
First Post:
2020-08-14
Brief Title:
Elotuzumab for the Treatment of JAK2-Mutated Myelofibrosis
Sponsor:
MD Anderson Cancer Center
Organization:
MD Anderson Cancer Center
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Myelofibrosis Transformation in Essential Thrombocythemia |
| Polycythemia Vera Post-Polycythemic Myelofibrosis Phase |
| Primary Myelofibrosis |
Keywords: